Display Settings:

Format

Send to:

Choose Destination
Acta Reumatol Port. 2012 Jul-Sep;37(3):253-9.

Position paper on tuberculosis screening in patients with immune mediated inflammatory diseases candidates for biological therapy.

Author information

  • 1Centro de Referência de Tuberculose Multi-resistente da Região Norte. rdmelo@med.up.pt

Abstract

Chronic immunosuppression is a known risk factor for tuberculosis. Our aim was to reach a consensus on screening and prevention of tuberculosis in patients with immune mediated inflammatory diseases candidates to biologic therapy.

METHODS:

Critical appraisal of the literature and expert opinion on immunosuppressive therapies and risk of tuberculosis.

RESULTS AND CONCLUSION:

The currently recommended method for screening is the tuberculin skin test and the interferon gamma assay, after exclusion of active tuberculosis. Positively screened patients should be treated for latent tuberculosis infection. Patients may start biological therapy after 1 to 2 months, as long as they are strictly adhering to and tolerating their preventive regimen.

PMID:
23348114
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk